Neumar, C., Wang, W., Sellner, L., Suryanarayan, K., Zhou, X. (2025). Optimizing elritercept benefit-risk profile by response-based adaptive dosing in patients with low-risk Myelodysplastic Syndromes (LR-MDS). Blood. https://doi.org/10.1182/blood-2025-2089